A new N-silyl sulfinylamine reagent allows the rapid preparation of a broad range of (hetero)aryl, alkenyl, and alkyl primary sulfinamides, using Grignard, organolithium, or organozinc reagents to introduce the carbon fragment. Treatment of these primary sulfinamides with an amine in the presence of a hypervalent iodine reagent leads directly to NH-sulfonimidamides. This two-step sequence is straightforward to perform and provides a modular approach to sulfonimidamides, allowing ready variation of both reaction components, including primary and secondary amines.
A new N-silyl sulfinylamine reagent allows the rapid preparation of a broad range of (hetero)aryl, alkenyl, and alkyl primary sulfinamides, using Grignard, organolithium, or organozinc reagents to introduce the carbon fragment. Treatment of these primary sulfinamides with an amine in the presence of a hypervalent iodine reagent leads directly to NH-sulfonimidamides. This two-step sequence is straightforward to perform and provides a modular approach to sulfonimidamides, allowing ready variation of both reaction components, including primary and secondary amines.
Sulfonimidamides[1] are becoming established
as valuable motifs in medicinal
chemistry[2] and feature in molecules used
in an increasing range of therapeutic areas.[3] The growth in use of sulfonimidamides has been mirrored by recent
innovations[4] in their synthesis.[5] Approaches that employ sulfonimidoyl halides,[6] or sulfonimidates,[7] have been used extensively; however, access to these substrates
can be challenging. The imination, or imination/oxidation, of lower
oxidation-state precursors have emerged as useful methods to access
sulfonimidamides. In this context, Bull has shown that an iodosobenzene/ammonium
carbamate combination can be used to convert tertiary sulfenamides
directly to sulfonimidamides,[8] and Stockman
has employed related reagents with tertiary sulfinamide substrates
(Scheme a,b).[9] Both of these methods are efficient, and both
show commendable scope. However, both approaches are essentially linear;
the last step in each is installation of an imidic NH group to a functionalized
precursor, where the key S–N bond, linking the S-fragment and
the N-fragment, has been established earlier in the reaction sequence.
To provide more convergency, and to enable analogue synthesis, we
conceived of an approach to NH-sulfonimidamides in which primary sulfinamides
are combined with diversely substituted amines, using a hypervalent
iodine reagent, as the final step of the synthesis (Scheme d). Our confidence in the success
of this final step was due to in part to the chemistry from Bull,
and Stockman, but also to the pioneering work from Malacria and Fensterbank,
who converted primary sulfinamides into sulfonimidates using iodosobenzene
with alcoholic solvents (Scheme c).[10]
Scheme 1
(a–c) Hypervalent-Iodine
Mediated Synthesis of Sulfonimidamides
and Sulfonimidates; (d) This Work: A Modular Route
to Sulfonimidamides
To deliver a flexible,
fully modular sulfonimidamide synthesis,
our approach would also require a straightforward method to access
primary sulfinamides. Although a number of primary sulfinamide syntheses
are known, most require several steps,[11] or the need to use thiol substrates;[12] we wished to avoid both of these constraints. To address this, we
proposed the combination of a suitable sulfinylamine reagent with
an organometallic nucleophile, which should directly provide the required
primary sulfinamides (Scheme d). Herein, we report the successful realization of this plan.Although sulfinylamines (R-NSO) have been known for over 140 years,[13] there has only recently been a flurry of activity
using these reagents.[14,5d,6a,7a,15] For our proposed
synthesis we required a sulfinylamine reagent with an N-substituent
that would be easily removed using mild conditions, ideally avoiding
strongly acidic or basic media. To meet these requirements, we settled
on a N-silyl substituted reagent, and initially considered
the N-triphenylsilyl derivative, originally prepared
by Ismail and co-workers.[16] However, it
was soon apparent that the N-triphenylsilyl sulfinylamine
was prone to hydrolysis, and its use after storage was challenging.
To achieve the desired balance between stability and reactivity, we
turned to the N-triisopropylsilyl derivative 1. This novel sulfinylamine could be prepared on a multigram
scale, in high yield, in two steps starting from triisopropylsilyl
chloride and ammonia (Scheme ). Reagent 1 is a light-yellow colored liquid
that is stable to refrigerated storage for at least one month.[17]
Scheme 2
Preparation of Triisopropylsilyl Sulfinylamine 1
Sulfinylamine 1 (TIPS-NSO) showed good reactivity
with a broad range of Grignard, organolithium, and organozinc reagents
(Scheme ). Although
the intermediate N-silyl sulfinamides could be isolated,
it was more convenient to treat the reaction mixtures directly with
TBAF to form the desired primary sulfinamides. In this way, aryl organometallics
of varied steric (2a–2c) and electronic
character (2d–2f) could be smoothly
converted to the corresponding primary sulfinamides in excellent yields.
A gram-scale reaction provided p-fluoro-derivative 2d in 89% yield. Heteroaryl organometallics derived from pyridine,
thiophene, and benzofuran could be employed (2g–2j). Alkyl sulfinamides could also be prepared, with representative
primary, benzylic, secondary, and tertiary Grignard reagents being
used (2k–2n). An alkenyl-Grignard
reagent was also successful (2o). Finally, the aryl core
of the COX-2 inhibitor Celecoxib was incorporated (2p).
Scheme 3
Synthesis of Primary Sulfinamides 2
Reaction conditions: TIPS-NSO
(1.00 equiv), R-[M] (1.20 equiv), THF (0.1 M), 0 °C, 5 min; then TBAF (2.00 equiv), 0 °C to rt, 10 min. Isolated
yields.
Commercial Grignard
reagent.
Organolithium
reagent, generated using lithium-halogen exchange (n-BuLi).
Grignard reagent,
generated from aryl bromide using i-Pr-MgCl.LiCl.
Organolithium reagent, generated
by deprotonation, using n-BuLi.
Using Ar-ZnCl, generated from Grignard
reagent and ZnCl2.
Synthesis of Primary Sulfinamides 2
Reaction conditions: TIPS-NSO
(1.00 equiv), R-[M] (1.20 equiv), THF (0.1 M), 0 °C, 5 min; then TBAF (2.00 equiv), 0 °C to rt, 10 min. Isolated
yields.Commercial Grignard
reagent.Organolithium
reagent, generated using lithium-halogen exchange (n-BuLi).Grignard reagent,
generated from aryl bromide using i-Pr-MgCl.LiCl.Organolithium reagent, generated
by deprotonation, using n-BuLi.Using Ar-ZnCl, generated from Grignard
reagent and ZnCl2.With a selection
of primary sulfinamides readily available, our
attention turned to their conversion into sulfonimidamides. An efficient
procedure was established, involving treating the sulfinamide with
the desired amine in the presence of 1.5 equiv of PhI(OAc)2, using triethylamine as base (Scheme ). Applying this procedure, using morpholine as the
amine component, allowed all of the primary sulfinamides shown in Scheme to be smoothly converted
into the corresponding sulfonimidamides. The reactions were performed
at ambient temperature, for between 1.5 and 23 h. The para-fluoro example (3d) was prepared on a gram scale (2.3
g) in an identical yield (92%) to that achieved in the smaller-scale
scoping experiments. The para-fluorophenyl sulfinamide
(2d) was then used to explore the range of secondary
amines that could be used. Cyclic examples substituted with cyano
and ketone groups performed well (3q, 3r). Acyclic amines featuring pyridyl and cyclohexylmethyl groups were
also included (3s, 3t). The remainder of
the amines used were selected as they feature in marketed pharmaceuticals
(Clopidogrel 3u, Perospirone 3v, Buspirone 3w, Amoxapine 3x), and as can be seen, these
more complex, heterocylic scaffolds provided the desired sulfonimidamides
in generally excellent yields.
Scheme 4
Conversion of Primary Sulfinamides
into Sulfonimidamides, Using Secondary
Amine Nucleophiles
Conversion of Primary Sulfinamides
into Sulfonimidamides, Using Secondary
Amine Nucleophiles
Reaction conditions: sulfinamide 2a–p (1.0 equiv), amine (1.5 equiv), PhI(OAc)2 (1.5 equiv), Et3N (3.0 equiv), toluene (0.1 M),
rt. Isolated yields.All of the amines used
in Scheme are secondary
amines; primary amines were poor substrates
using the original reaction conditions, generally providing only 5–10%
of product. After optimization (see Supporting Information), we were able to identify suitable conditions
for primary amine substrates. The new conditions required the use
of the more robust hypervalent iodine reagent PhI(OC(O)t-Bu)2,[18] a greater excess of
triethylamine, and an increased reaction temperature of 60 °C.
These modified conditions were successfully applied to a range of
primary amines, including primary alkyl (4a–c) and secondary alkyl (4d, 4e),
using the para-fluorophenyl sulfinamide (2d) as the substrate. Amines featuring alkyne (4f, 4g) and alkene (4h) groups could be used (Scheme ). The final example
establishes that these new conditions could also be extended to a
heterocyclic sulfinamide substrate (4i). The successful
use of primary amines to prepare the corresponding sulfonimidamides
is notable, as neither the Bull nor Stockman approaches shown in Scheme could accommodate
this class of amine.[8,9]
Scheme 5
Conversion of Primary
Sulfinamides into Sulfonimidamides, Using Primary
Amine Nucleophiles
Reaction conditions: sulfinamide
(1.0 equiv), amine (2.0 equiv), PhI(OC(O)t-Bu)2 (2.5 equiv), Et3N (12.0 equiv), MeCN (0.1 M),
60 °C, 16 h. Isolated yields.
Conversion of Primary
Sulfinamides into Sulfonimidamides, Using Primary
Amine Nucleophiles
Reaction conditions: sulfinamide
(1.0 equiv), amine (2.0 equiv), PhI(OC(O)t-Bu)2 (2.5 equiv), Et3N (12.0 equiv), MeCN (0.1 M),
60 °C, 16 h. Isolated yields.As a final
demonstration of the utility of the developed method,
we targeted the preparation of a more complex sulfonimidamide derivative
(Scheme ). Pyrimidinone-substituted
aryl bromide 5 contains the aryl core of the marketed
PDE5-inhibitor Sildenafil. Lithiation of bromide 5 using
a combination of MeLi and n-BuLi generated an aryl
lithium reagent that underwent smooth addition into TIPS-NSO. In situ
treatment with TBAF then provided complex primary sulfinamide 6 in an excellent 89% yield. The coupling of sulfinamide 6 with N-methyl piperazine required the use
of DBU in place of triethylamine and MeCN as solvent; with these modifications,
sulfonimidamide 7,[7a] the monoaza
analogue of Sildenafil, was isolated in 64% yield.
Scheme 6
Synthesis of Sildenafil
Analogue 7
In summary, we have developed a modular, two-step synthesis of
sulfonimidamides, with organometallics such as Grignard, organolithium,
or organozinc reagents, and amines, being the key building blocks.
This strategy alleviates the necessity of thiol starting materials.
A new N-silyl sulfinylamine reagent is introduced
that allows ready preparation of a broad range of primary sulfinamides.
The convergent nature of this approach should be attractive to medicinal
chemists preparing collections of sulfonimidamides or sulfinamides.
Authors: Fernando Sehgelmeble; Juliette Janson; Colin Ray; Susanne Rosqvist; Susanne Gustavsson; Linda I Nilsson; Alexander Minidis; Jörg Holenz; Didier Rotticci; Johan Lundkvist; Per I Arvidsson Journal: ChemMedChem Date: 2012-02-03 Impact factor: 3.466
Authors: Charlotte S Richards-Taylor; Carolina Martínez-Lamenca; Joseph E Leenaerts; Andres A Trabanco; Daniel Oehlrich Journal: J Org Chem Date: 2017-08-30 Impact factor: 4.354
Authors: Anne Felim; Aurélie Toussaint; Courtney R Phillips; Dominique Leca; Anna Vagstad; Louis Fensterbank; Emmanuel Lacôte; Max Malacria Journal: Org Lett Date: 2006-01-19 Impact factor: 6.005
Authors: Christian Gege; Fernando J Bravo; Nadja Uhlig; Timo Hagmaier; Rosanne Schmachtenberg; Julia Elis; Anke Burger-Kentischer; Doris Finkelmeier; Klaus Hamprecht; Thomas Grunwald; David I Bernstein; Gerald Kleymann Journal: Sci Transl Med Date: 2021-06-16 Impact factor: 17.956